These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32763973)

  • 1. Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover.
    Alexander KL; Serrano CA; Chakraborty A; Nearing M; Council LN; Riquelme A; Garrido M; Bellis SL; Smythies LE; Smith PD
    J Biol Chem; 2020 Oct; 295(41):14153-14163. PubMed ID: 32763973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
    Schultz MJ; Holdbrooks AT; Chakraborty A; Grizzle WE; Landen CN; Buchsbaum DJ; Conner MG; Arend RC; Yoon KJ; Klug CA; Bullard DC; Kesterson RA; Oliver PG; O'Connor AK; Yoder BK; Bellis SL
    Cancer Res; 2016 Jul; 76(13):3978-88. PubMed ID: 27216178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
    Holdbrooks AT; Britain CM; Bellis SL
    J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
    Dorsett KA; Jones RB; Ankenbauer KE; Hjelmeland AB; Bellis SL
    J Ovarian Res; 2019 Oct; 12(1):93. PubMed ID: 31610800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.
    Jones RB; Dorsett KA; Hjelmeland AB; Bellis SL
    J Biol Chem; 2018 Apr; 293(15):5659-5667. PubMed ID: 29475939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells.
    Swindall AF; Bellis SL
    J Biol Chem; 2011 Jul; 286(26):22982-90. PubMed ID: 21550977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.
    Liu Z; Swindall AF; Kesterson RA; Schoeb TR; Bullard DC; Bellis SL
    J Biol Chem; 2011 Nov; 286(45):39654-62. PubMed ID: 21930713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
    Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
    Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.
    Britain CM; Dorsett KA; Bellis SL
    J Biol Chem; 2017 Mar; 292(11):4663-4673. PubMed ID: 28154177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
    Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of inflammatory signaling by the ST6Gal-I sialyltransferase.
    Holdbrooks AT; Ankenbauer KE; Hwang J; Bellis SL
    PLoS One; 2020; 15(11):e0241850. PubMed ID: 33166339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.
    Britain CM; Holdbrooks AT; Anderson JC; Willey CD; Bellis SL
    J Ovarian Res; 2018 Feb; 11(1):12. PubMed ID: 29402301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.
    Gretschel S; Haensch W; Schlag PM; Kemmner W
    Oncology; 2003; 65(2):139-45. PubMed ID: 12931020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.
    Swindall AF; Londoño-Joshi AI; Schultz MJ; Fineberg N; Buchsbaum DJ; Bellis SL
    Cancer Res; 2013 Apr; 73(7):2368-78. PubMed ID: 23358684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of α2,3-sialyltransferase I and α2,6-sialyltransferase I in human cutaneous epithelial lesions.
    Ferreira SA; Vasconcelos JL; Silva RC; Cavalcanti CL; Bezerra CL; Rêgo MJ; Beltrão EI
    Eur J Histochem; 2013 Feb; 57(1):e7. PubMed ID: 23549466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing HER2 α2,6 sialylation facilitates gastric cancer progression and resistance via the Akt and ERK pathways.
    Liu N; Zhu M; Linhai Y; Song Y; Gui X; Tan G; Li J; Liu Y; Deng Z; Chen X; Wang J; Jia L; He X; Wang X; Lin S
    Oncol Rep; 2018 Nov; 40(5):2997-3005. PubMed ID: 30226606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.
    Dall'Olio F; Chiricolo M; D'Errico A; Gruppioni E; Altimari A; Fiorentino M; Grigioni WF
    Glycobiology; 2004 Jan; 14(1):39-49. PubMed ID: 14514712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer.
    Smithson M; Irwin R; Williams G; Alexander KL; Smythies LE; Nearing M; McLeod MC; Al Diffalha S; Bellis SL; Hardiman KM
    J Biol Chem; 2022 Mar; 298(3):101594. PubMed ID: 35041825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.
    Wang L; Li S; Yu X; Han Y; Wu Y; Wang S; Chen X; Zhang J; Wang S
    J Physiol Biochem; 2019 Jun; 75(2):199-207. PubMed ID: 30972697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ST6GAL1 and ST6GAL2 in subversion of cellular signaling during enteroaggregative Escherichia coli infection of human intestinal epithelial cell lines.
    Chandel S; Joon A; Kaur S; Ghosh S
    Appl Microbiol Biotechnol; 2023 Feb; 107(4):1405-1420. PubMed ID: 36646912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.